Medicure Inc. (MPH.V)
CAD 0.83
(0.0%)
CAD 0.83
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -854 Thousand CAD | -165.19% |
| 2022 | 1.31 Million CAD | 328.22% |
| 2021 | -574 Thousand CAD | 92.12% |
| 2020 | -7.28 Million CAD | 32.07% |
| 2019 | -10.72 Million CAD | -774.88% |
| 2018 | -1.22 Million CAD | -133.57% |
| 2017 | 3.65 Million CAD | -45.35% |
| 2016 | 6.68 Million CAD | 41.57% |
| 2015 | 4.72 Million CAD | 324.13% |
| 2014 | 1.11 Million CAD | 576.99% |
| 2013 | 164.41 Thousand CAD | 107.88% |
| 2012 | -2.08 Million CAD | -20776.99% |
| 2011 | 10.09 Thousand CAD | 100.81% |
| 2010 | -1.24 Million CAD | 64.41% |
| 2009 | -3.5 Million CAD | 49.87% |
| 2008 | -6.99 Million CAD | 83.25% |
| 2007 | -41.74 Million CAD | -34.16% |
| 2006 | -31.11 Million CAD | -141.48% |
| 2005 | -12.88 Million CAD | 16.43% |
| 2004 | -15.41 Million CAD | -157.46% |
| 2003 | -5.98 Million CAD | -42.81% |
| 2002 | -4.19 Million CAD | -8.22% |
| 2001 | -3.87 Million CAD | -19.9% |
| 2000 | -3.23 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 38 Thousand CAD | 102.38% |
| 2024 Q2 | -1.11 Million CAD | -3042.11% |
| 2023 Q2 | 327 Thousand CAD | 0.31% |
| 2023 FY | -854 Thousand CAD | -165.19% |
| 2023 Q1 | 326 Thousand CAD | -60.44% |
| 2023 Q3 | 108 Thousand CAD | -66.97% |
| 2023 Q4 | -1.59 Million CAD | -1578.7% |
| 2022 Q4 | 824 Thousand CAD | 52.59% |
| 2022 Q3 | 540 Thousand CAD | 139.19% |
| 2022 Q2 | -1.37 Million CAD | -785.57% |
| 2022 Q1 | 201 Thousand CAD | -86.11% |
| 2022 FY | 1.31 Million CAD | 328.22% |
| 2021 Q2 | -600 Thousand CAD | 35.14% |
| 2021 Q4 | 1.44 Million CAD | 389.98% |
| 2021 Q1 | -925 Thousand CAD | 65.93% |
| 2021 FY | -574 Thousand CAD | 92.12% |
| 2021 Q3 | -499 Thousand CAD | 16.83% |
| 2020 Q3 | -528 Thousand CAD | 42.42% |
| 2020 FY | -7.28 Million CAD | 32.07% |
| 2020 Q1 | -3.12 Million CAD | 60.97% |
| 2020 Q2 | -917 Thousand CAD | 70.67% |
| 2020 Q4 | -2.71 Million CAD | -414.2% |
| 2019 Q1 | -2.14 Million CAD | 11.78% |
| 2019 FY | -10.72 Million CAD | -774.88% |
| 2019 Q2 | -321 Thousand CAD | 85.01% |
| 2019 Q3 | -1.94 Million CAD | -506.54% |
| 2019 Q4 | -8.01 Million CAD | -311.5% |
| 2018 Q3 | 286.05 Thousand CAD | 145.71% |
| 2018 FY | -1.22 Million CAD | -133.57% |
| 2018 Q1 | 435.06 Thousand CAD | 128.54% |
| 2018 Q4 | -2.42 Million CAD | -948.79% |
| 2018 Q2 | -625.78 Thousand CAD | -243.84% |
| 2017 Q3 | 1.8 Million CAD | -42.71% |
| 2017 FY | 3.65 Million CAD | -45.35% |
| 2017 Q1 | -4.43 Million CAD | -292.28% |
| 2017 Q4 | -1.52 Million CAD | -184.29% |
| 2017 Q2 | 3.15 Million CAD | 171.19% |
| 2016 Q3 | 2.46 Million CAD | 259.18% |
| 2016 Q2 | 687.44 Thousand CAD | -43.69% |
| 2016 FY | 6.68 Million CAD | 41.57% |
| 2016 Q1 | 1.22 Million CAD | -67.89% |
| 2016 Q4 | 2.3 Million CAD | -6.61% |
| 2015 Q2 | 600.94 Thousand CAD | 25.12% |
| 2015 Q4 | 3.8 Million CAD | 2431.86% |
| 2015 Q1 | 480.31 Thousand CAD | 0.0% |
| 2015 FY | 4.72 Million CAD | 324.13% |
| 2015 Q3 | -163.07 Thousand CAD | -127.14% |
| 2014 Q3 | 462.8 Thousand CAD | 359.05% |
| 2014 Q2 | 100.81 Thousand CAD | -79.66% |
| 2014 Q1 | 495.61 Thousand CAD | 239.04% |
| 2014 FY | 1.11 Million CAD | 576.99% |
| 2013 Q2 | -647.72 Thousand CAD | 30.19% |
| 2013 FY | 164.41 Thousand CAD | 107.88% |
| 2013 Q4 | -356.45 Thousand CAD | 3.84% |
| 2013 Q3 | -370.7 Thousand CAD | 42.77% |
| 2013 Q1 | -927.85 Thousand CAD | -167.74% |
| 2012 Q1 | -224.61 Thousand CAD | -119.08% |
| 2012 Q2 | 22.92 Million CAD | 10306.39% |
| 2012 Q3 | -164.39 Thousand CAD | -100.72% |
| 2012 Q4 | -346.55 Thousand CAD | -110.81% |
| 2012 FY | -2.08 Million CAD | -20776.99% |
| 2011 Q2 | -1.28 Million CAD | -2870.66% |
| 2011 Q3 | 56.77 Thousand CAD | 104.4% |
| 2011 Q4 | 1.17 Million CAD | 1973.48% |
| 2011 Q1 | 46.54 Thousand CAD | 102.63% |
| 2011 FY | 10.09 Thousand CAD | 100.81% |
| 2010 Q3 | -282.22 Thousand CAD | 53.7% |
| 2010 Q4 | -1.76 Million CAD | -526.47% |
| 2010 FY | -1.24 Million CAD | 64.41% |
| 2010 Q1 | -1.44 Million CAD | -224.58% |
| 2010 Q2 | -609.57 Thousand CAD | 57.95% |
| 2009 Q2 | -3.38 Million CAD | -77.59% |
| 2009 Q3 | -998.76 Thousand CAD | 70.46% |
| 2009 Q4 | -446.63 Thousand CAD | 55.28% |
| 2009 FY | -3.5 Million CAD | 49.87% |
| 2009 Q1 | -1.9 Million CAD | -62.31% |
| 2008 Q4 | -1.17 Million CAD | -119.58% |
| 2008 Q3 | -534.12 Thousand CAD | 76.61% |
| 2008 FY | -6.99 Million CAD | 83.25% |
| 2008 Q1 | -9 Million CAD | 42.36% |
| 2008 Q2 | -2.28 Million CAD | 74.65% |
| 2007 Q4 | -15.62 Million CAD | -5.46% |
| 2007 Q2 | -13.24 Million CAD | -58.19% |
| 2007 Q1 | -8.36 Million CAD | -47.04% |
| 2007 FY | -41.74 Million CAD | -34.16% |
| 2007 Q3 | -14.82 Million CAD | -11.94% |
| 2006 Q1 | -2.76 Million CAD | 21.7% |
| 2006 Q4 | -5.69 Million CAD | -49.32% |
| 2006 Q2 | -2.7 Million CAD | 1.97% |
| 2006 Q3 | -3.81 Million CAD | -40.79% |
| 2006 FY | -31.11 Million CAD | -141.48% |
| 2005 Q3 | -3.76 Million CAD | 23.31% |
| 2005 Q4 | -3.52 Million CAD | 6.19% |
| 2005 FY | -12.88 Million CAD | 16.43% |
| 2005 Q1 | -4.27 Million CAD | -17.86% |
| 2005 Q2 | -4.9 Million CAD | -14.71% |
| 2004 Q4 | -3.62 Million CAD | -38.67% |
| 2004 FY | -15.41 Million CAD | -157.46% |
| 2004 Q2 | -2.17 Million CAD | -48.2% |
| 2004 Q3 | -2.61 Million CAD | -20.23% |
| 2004 Q1 | -1.46 Million CAD | -17.72% |
| 2003 FY | -5.98 Million CAD | -42.81% |
| 2003 Q1 | -917.33 Thousand CAD | 25.41% |
| 2003 Q2 | -897.46 Thousand CAD | 2.17% |
| 2003 Q4 | -1.24 Million CAD | -13.39% |
| 2003 Q3 | -1.09 Million CAD | -22.51% |
| 2002 Q3 | -1.2 Million CAD | 0.0% |
| 2002 FY | -4.19 Million CAD | -8.22% |
| 2002 Q4 | -1.22 Million CAD | -1.95% |
| 2001 FY | -3.87 Million CAD | -19.9% |
| 2000 FY | -3.23 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.82 Million CAD | 69.719% |
| CanadaBis Capital Inc. | 4.67 Million CAD | 118.26% |
| Decibel Cannabis Company Inc. | 1.41 Million CAD | 160.482% |
| Delivra Health Brands Inc. | -710 Thousand CAD | -20.282% |
| Entourage Health Corp. | -21.37 Million CAD | 96.005% |
| Lifeist Wellness Inc. | -12.24 Million CAD | 93.029% |
| Cannara Biotech Inc. | 11.88 Million CAD | 107.184% |
| PharmaCielo Ltd. | -9.7 Million CAD | 91.197% |
| Rubicon Organics Inc. | -1.08 Million CAD | 21.177% |
| BioSyent Inc. | 7.47 Million CAD | 111.431% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 30.055% |